These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26622699)

  • 1. Expression and clinical significance of tyrosine phosphatase SHP2 in thyroid carcinoma.
    Hu ZQ; Ma R; Zhang CM; Li J; Li L; Hu ZT; Gao QI; Li WM
    Oncol Lett; 2015 Sep; 10(3):1507-1512. PubMed ID: 26622699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells.
    Liotti F; Kumar N; Prevete N; Marotta M; Sorriento D; Ieranò C; Ronchi A; Marino FZ; Moretti S; Colella R; Puxeddu E; Paladino S; Kano Y; Ohh M; Scala S; Melillo RM
    J Exp Clin Cancer Res; 2021 Jan; 40(1):22. PubMed ID: 33413561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tyrosine phosphatase SHP2 gain-of-function mutation enhances malignancy of breast carcinoma.
    Hu Z; Wang X; Fang H; Liu Y; Chen D; Zhang Q; Liu X; Wei D; Qu C; Wang S
    Oncotarget; 2016 Feb; 7(5):5664-76. PubMed ID: 26673822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical significance of SHP2 in gastric cancer.
    Dong S; Li FQ; Zhang Q; Lv KZ; Yang HL; Gao Y; Yu JR
    J Int Med Res; 2012; 40(6):2083-9. PubMed ID: 23321164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHP2 is involved in the occurrence, development and prognosis of cancer.
    Li S; Qu J; Wang X; Zou Q; Li C
    Oncol Lett; 2023 Sep; 26(3):393. PubMed ID: 37600341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.
    Chen YN; LaMarche MJ; Chan HM; Fekkes P; Garcia-Fortanet J; Acker MG; Antonakos B; Chen CH; Chen Z; Cooke VG; Dobson JR; Deng Z; Fei F; Firestone B; Fodor M; Fridrich C; Gao H; Grunenfelder D; Hao HX; Jacob J; Ho S; Hsiao K; Kang ZB; Karki R; Kato M; Larrow J; La Bonte LR; Lenoir F; Liu G; Liu S; Majumdar D; Meyer MJ; Palermo M; Perez L; Pu M; Price E; Quinn C; Shakya S; Shultz MD; Slisz J; Venkatesan K; Wang P; Warmuth M; Williams S; Yang G; Yuan J; Zhang JH; Zhu P; Ramsey T; Keen NJ; Sellers WR; Stams T; Fortin PD
    Nature; 2016 Jul; 535(7610):148-52. PubMed ID: 27362227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z; Hao XY; Liu FX
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles.
    Hu Z; Yang B; Li T; Li J
    Contrast Media Mol Imaging; 2018; 2018():8710862. PubMed ID: 29706844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of SHP2/PTPN11 in the occurrence and prognosis of cancer: A systematic review and meta-analysis.
    Li S; Wang X; Li Q; Li C
    Oncol Lett; 2023 Jan; 25(1):19. PubMed ID: 36478896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Src homology phosphotyrosyl phosphatase-2 expression is an independent negative prognostic factor in human breast cancer.
    Muenst S; Obermann EC; Gao F; Oertli D; Viehl CT; Weber WP; Fleming T; Gillanders WE; Soysal SD
    Histopathology; 2013 Jul; 63(1):74-82. PubMed ID: 23672411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functions of Shp2 in cancer.
    Zhang J; Zhang F; Niu R
    J Cell Mol Med; 2015 Sep; 19(9):2075-83. PubMed ID: 26088100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3.
    Qi C; Han T; Tang H; Huang K; Min J; Li J; Ding X; Xu Z
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
    Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
    Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-223 inhibitor suppresses proliferation and induces apoptosis of thyroid cancer cells by down-regulating aquaporin-1.
    Zhang Q; Lin L; Li W; Lu G; Li X
    J Recept Signal Transduct Res; 2019 Apr; 39(2):146-153. PubMed ID: 31311397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Src homology phosphotyrosyl phosphatase 2 (Shp2) expression in oral cancer and knockdown of Shp2 expression inhibit tumor cell viability and invasion in vitro.
    Xie H; Huang S; Li W; Zhao H; Zhang T; Zhang D
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):234-42. PubMed ID: 24439919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decorin impeded the advancement of thyroid papillary carcinoma by thwarting the EGFR/ FER/ SHP2 signaling-induced sustenance of early endosomes.
    Liu Y; Xin Y; Lv T; Chang Z; Xue G; Shang X
    Heliyon; 2024 Jul; 10(13):e33358. PubMed ID: 39035505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHP2 promotes laryngeal cancer growth through the Ras/Raf/Mek/Erk pathway and serves as a prognostic indicator for laryngeal cancer.
    Gu J; Han T; Ma RH; Zhu YL; Jia YN; Du JJ; Chen Y; Jiang XJ; Xie XD; Guo X
    Int J Oncol; 2014 Feb; 44(2):481-90. PubMed ID: 24297342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and prognostic significance of SHP2 and Hook1 expression in patients with thyroid carcinoma.
    Cao J; Huang YQ; Jiao-Sun ; Lan XB; Ge MH
    Hum Pathol; 2018 Nov; 81():105-112. PubMed ID: 29953894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHP2 overexpression enhances the invasion and metastasis of ovarian cancer in vitro and in vivo.
    Hu Z; Li J; Gao Q; Wei S; Yang B
    Onco Targets Ther; 2017; 10():3881-3891. PubMed ID: 28814887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.
    Han T; Xiang DM; Sun W; Liu N; Sun HL; Wen W; Shen WF; Wang RY; Chen C; Wang X; Cheng Z; Li HY; Wu MC; Cong WM; Feng GS; Ding J; Wang HY
    J Hepatol; 2015 Sep; 63(3):651-60. PubMed ID: 25865556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.